Overview
Born in Durham, North Carolina but raised in Potsdam, New York, Dr. Grimberg joins Asheville Urological Associates after finishing his Urology residency at Duke University. He attended Cornell University for his undergraduate studies in biological engineering and studied medicine at Case Western Reserve University.
Dr. Grimberg specializes in robotic, laparoscopic, endoscopic, and open urologic surgeries. He is interested in full spectrum general urology including the medical and surgical management of cancers of the genitourinary system, enlarged prostate, kidney stones, urinary incontinence, and erectile dysfunction among many other urologic conditions.
Education
Universities
- Cornell University - Biological engineering
- Case Western Reserve University - Medicine
Professional association
- Member American Urological Association
- American Board of Urology - Board Eligible (Part 1 passed, Part 2 pending in 2025)
Expertise and interests
Expert in
Minimally Invasive Surgery
Interests
Urologic Oncology
Awards and honors
- AUA Urology Care Foundation Resident Research Grant 2019
- NCUA Debate Winner 2019
- Alpha Omega Alpha Honor Society
- Case Western Dean’s Summer Research Award 2013
Publications
- K. E. Morris, D. C. Grimberg, R. Arcot, and J. W. Moul, “Aggressive prostate cancer masquerading as acute prostatitis,” Can J Urol, vol. 28, no. 4, pp. 10799–10801, Aug. 2021.
- D. C. Grimberg, J. Dudinec, A. Shah, B. A. Inman. “Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.” Urologic Oncolology: Seminars and Original Investigations. 2021 Aug;39(8):498.e13- 498.e20.
- L. J. Wilkins, J. J. Tosoian, D. Sundi, A. E. Ross, D. C. Grimberg, E. A. Klein, B. F. Chapin, Y. A. Nyame. “Surgical management of high-risk, localized prostate cancer,” Nature Reviews Urology, vol. 17, no. 12, Art. no. 12, Dec. 2020, doi:
- D. C. Grimberg, S. Wang, E. C. Carlos, B. D. Nosé, S. Harper, A.C. Lentz, “Counter incision is a safe and effective method for alternative reservoir placement during inflatable penile prosthesis surgery,” Translational Andrology and Urology. 2020 Dec 9(6):2688-2696.
- D. C. Grimberg, A. Shah, W. P. Tan, W. Etienne, I. Spasojevic, B. I. Inman, “Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents,” Bladder Cancer, vol. 6, no. 4, Jan 2020, pp. 461- 70.
- A. Shah, D. C. Grimberg, and B. A. Inman, “Classification of Molecular Biomarkers,” SIUJ, vol. 1, no. 1, p. 8, 2020.
- R. B. Qi, D. C. Grimberg, A. C. Lentz. Management of Urethral Injury During Penile Prosthesis Surgery. Curr Sex Health Rep. Vol 12. 2020 Mar 9, pp. 62-67.
- A. Shah, D. C. Grimberg, B. A. Inman. From Dog’s Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer. European Urology., vol. 78, no. 3, Sept. 2020, pp. 400–01.
- D. C. Grimberg, A. Shah, B. A. Inman. En Bloc Resection of Bladder Tumors: Style or Substance? Eur Urol, vol. 78, no. 4, Oct. 2020, pp. 570–71.
- D. C. Grimberg, A. Shah, J. Molinger, J. Whittle, R.T. Gupta, P.E. Wischmeyer, et al. Assessments of frailty in bladder cancer. Urologic Oncology: Seminars and Original Investigations. 2020 May.
- B. D. Nose, D. C. Grimberg, A. C. Lentz. Update on Intraoperative Cultures, Biofilms and Modifiable Factors During Revision of Clinically Non-infected Penile Implants. Sexual Medicine Reviews. Vol. 9, No. 1, 2021, pp. 160-168.
- W. P. Tan, A. Chang, S. C. Brousell, D. C. Grimberg, J. J. Fantony, T. A. Longo, et al. Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study. International Journal of Hyperthermia. 2020 Jan 1;37(1):854–60.
- D. C. Grimberg, A. Shah, B.A. Inman. “Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.” Eur Urol Focus Sept 2019.
- Y. A. Nyame, D. C. Grimberg, D.J. Greene, K. Gupta, G.K. Kartha, R. Berglund, M. Gong, A.J. Stephenson, C. Magi-Galluzzi, E.A. Klein. “Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance”. J Urol. Sept 2017.